Global Automated and Rapid Microbiological Tests Market to Reach US$4.0 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Automated and Rapid Microbiological Tests market. Buoyed by the surging use of rapid tests in both clinical and non-clinical applications, the global market for Automated and Rapid Microbiological tests is forecast to reach US$4.0 billion by the year 2015. High prevalence of infectious diseases and sexually transmitted diseases is expected to drive the future of automated and rapid tests, as the need for quicker, higher volume and more accurate methods of testing gains importance.
San Jose, CA (Vocus) September 15, 2010
Automated and rapid microbiological tests have been gaining importance across the world as a major area for research and application to examine various kinds of microorganisms that are root cause for several diseases. With humans and bacteria locked in a perennial biological warfare, the future of the automated and rapid microbiological tests looks promising. Global demand for automated and rapid microbiological tests is characterized by technology developments and innovations. With probe tests threatening the survival of immunoassay based rapid tests and with advances in automated microbiological testing systems promising potential opportunities, the landscape is fraught with a unique mixture of opportunities and related threats.
Advances in automated testing are expected to help boost growth in clinical diagnostics and blood screening segments of the market. The trend towards automated instrumentation is aided by the promise of overall cost effectiveness and efficiency. Besides, rapid tests have a positive impact on public health, backed by its quick, rapid and accurate identification of an infection and its causative bacterium. By reducing the time taken for microbial identification, medical science gains an edge over infections and helps curb excessive and unwarranted use of antibiotics, while promptly ensuring a right course of treatment against the disease.
The United States represents the largest region for Automated and Rapid Microbiological Tests worldwide, as stated by the new market research report on Automated and Rapid Microbiological Tests. Europe represents the second largest market for automated and rapid tests in terms of sales. Increased patient awareness constitutes a key driver for the intensifying demand for rapid microbiology testing in the hospital setting. Aging of the affluent and educated baby boom population and the rising incidences of antibiotic resistant infections among the hospital population have created lucrative opportunities for the expanded use of automated and rapid microbiological tests. Future market growth is expected to stem from developing countries, in Asia Pacific, Latin America and Middle East, where the trend towards laboratory conversion is gaining momentum by each passing year.
Automated Identification and Susceptibility Systems represent the largest segment under clinical end-use market, which accounts for more than 55% share of the automated and rapid microbiological testing market. In terms of growth, the fastest growth is likely to emanate from STD rapid tests, given the rising instances of sexually transmitted diseases (STDs). Rapid HIV Testing is on the rise primarily due to the increasing incidence of HIV infections around the world. Prenatal screening for HIV and tests performed at publicly funded Counseling and Testing (CT) programs represent two immediate markets for rapid HIV tests. A key trend noticed in the rapid testing market is combined HIV testing built on multiple sampling modalities.
Rapid microbiological testing is increasingly finding application in the food industry, as food companies, disillusioned with the existing quality control methods, resort to automated and rapid tests. Presently, there are more than 60 types of rapid tests available for food testing, with major companies around the world adopting these systems.
Major players profiled in the report include Abbott Laboratories, Alere Inc., Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Cellabs Pty Ltd., Celsis International Plc, Coris BioConcept, F. Hoffmann-La Roche Ltd., Gen-Probe Inc., Genzyme Diagnostics, MedMira Inc., Meridian Biosciences Inc., Orasure Technologies Inc., Orion Diagnostica Oy, Quidel Corp., Siemens Healthcare Diagnostics, and Thermo Fisher Scientific Inc.
The report titled “Automated and Rapid Microbiological Tests: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the different automated and rapid microbiological tests market globally, current trends, key growth drivers, new product introductions, recent industry activity, and profiles of major and niche market players worldwide. The report analyzes market data and analytics in terms of value for regions including US, Europe and Rest of World. Key end-use markets analyzed include Clinical (Automated Identification & Susceptibility Systems, Automated Blood Culture Systems, Automated Tuberculosis Systems, Streptococcal Infection Rapid Tests, GC/Chlamydia Rapid Tests and Other Automated & Rapid Microbiological Tests) and Non-clinical.
For more details about this comprehensive market research report, please visit – http://www. strategyr. com/Automated_and_Rapid_Microbiological_Tests_Market_Report. asp.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www. StrategyR. com/
# # #